Rent the Runway Inc vs Relay Therapeutics Inc. Common Stock — how do they compare? Rent the Runway Inc trades at $1.84 (market cap $61.75M), while Relay Therapeutics Inc. Common Stock trades at $17.5 (market cap $3.82B). The key difference: Relay Therapeutics Inc. Common Stock is far larger — about 61.9× Rent the Runway Inc's market cap, and Relay Therapeutics Inc. Common Stock is trading nearer its 52-week high, Rent the Runway Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Rent the Runway Inc for 56 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| RENT | RLAY | |
|---|---|---|
Market Cap | $61.75M | $3.82B |
Volume | 193,323 | 4,332,079 |
Sector | Consumer Cyclical | Health |
52-Week High | $9.39 | $20.75 |
52-Week Low | $1.55 | $6.03 |
Typical Hold Time | 56 Days | 0 Days |
Enterprise Value | $228.75M | $2.93B |
Signals from Pluang's Aura AI — not financial advice
RENT trades at $1.68, up 1.82% today, amid a bearish technical signal and mixed fundamentals. The company reported Q2 2026 revenue growth of 20.8% YoY to $97.7M, with improved gross margins, but faces negative shareholder equity of -$182.5M and a high debt-to-asset ratio of 139.62. Recent CEO appointment and multiple law firm investigations create contrasting sentiment.
Outlook remains cautious due to persistent net losses, high leverage, and legal scrutiny, though revenue growth and margin expansion offer potential upside. Risks include execution challenges and debt burden, while analyst consensus leans Hold (57.89%) with no Sell ratings.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Rent the Runway Inc is an e-commerce platform that allows users to rent, subscribe, or buy designer apparel and accessories.
Read more on RENT →Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →